FLT3 and clear cell sarcoma of kidney: Intragenic tandem duplication is a well-known mechanism to activate oncogenes, for example, FLT3 internal tandem duplication (ITD) in acute myeloid leukemia and BCOR ITD in clear cell sarcoma of kidney (CCSK).